Asx Announcement Midkine Antibodies Effective in Cancer
ثبت نشده
چکیده
Since its discovery midkine’s role in cancer has been validated extensively. Approximately 200 peer-reviewed publications have been released on the topic, including four within the last three months. These studies, by multiple research groups around the world, show that MK is a key driver of tumorigenesis in at least 25 different types of cancers, including those of the breast, lung, colorectal, gastrointestinal, liver, pancreatic and brain.
منابع مشابه
Automatic Categorization of Announcements on the Australian Stock Exchange
This paper compares the performance of several machine learning algorithms for the automatic categorization of corporate announcements in the Australian Stock Exchange (ASX) Signal G data stream. The article also describes some of the applications that the categorization of corporate announcements may enable. We have performed tests on two categorization tasks: market sensitivity, which indicat...
متن کاملDoxorubicin-conjugated anti-midkine monoclonal antibody as a potential anti-tumor drug.
BACKGROUND Midkine is a heparin-binding growth factor preferentially expressed in tumor cells. The present study was performed to utilize anti-midkine antibody for tumor therapy. METHODS A monoclonal antibody to midkine was raised by immunizing mice deficient in the midkine gene. The binding site of the antibody was studied by using N-terminal half and C-terminal half of midkine, both of whic...
متن کاملMidkine in plasma as a novel breast cancer marker.
Midkine, a heparin-binding growth factor, is up-regulated in many types of cancer. The aim of this study was to measure plasma midkine levels in patients with breast cancer and to assess its clinical significance. We examined plasma midkine levels in 95 healthy volunteers, 11 patients with ductal carcinoma in situ (DCIS), 111 patients with primary invasive breast cancer without distant metastas...
متن کاملMidkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer
BACKGROUND To develop a novel therapeutic strategy for human pancreatic cancer using a midkine promoter-based conditionally replicating adenovirus. METHODS We examined midkine mRNA expression and midkine protein expression by seven human pancreatic cancer cell lines (AsPC-1, BxPC-3, CFPAC-1, HPAC, MIAPaCa-2, PANC-1, and Suit-2), as well as by non-cancerous pancreatic tissue and pancreatic can...
متن کامل